Skip to main content

Table 4 The laboratory findings of 7 patients with COVID-19 (Discharge)

From: Clinical features and outcomes of seven patients with COVID-19 in a family cluster

Variable case1 case2 case3 case4 case5 case6 case7
Laboratory findings
 PH(7.35–7.45) 7.37 7.389 7.401 7.394 7.395 7.379 7.349
 PO2(80-100 mmHg) 83.1 112 97.3 85 80.5 80.1 94.1
 PCO2(35-45 mmHg) 38.2 37.1 38 39 40.5 46.3 41.4
 OI(400-500 mmHg) 395 386 463 340 383 381 448
 White blood cell count (4–10 × 109/L) 5.33 5.7 3.65 7.8 6.07 4.71 4.42
 Neutrophil percentage (45–77%) 54.4 70.4 38.6 78.7 49.3 62 46.6
 Lymphocyte count (0.8–4 × 109/L) 1.9 1.33 1.87 0.94 2.47 1.26 1.84
 Haemoglobin (131-172 g /L) 151 130 138 89 169 132 142
 Eosinophil percentage (0.5–5%) 1.6 0.4 1.7 2.2 0.6 4.71 6.7
 Platelet count (100–300 × 109/L) 247 200 208 273 236 273 242
 ERS (0–20 mm/h) 12 32 10 82 21 20 5
CRP (0-8 mg /L) 1.23 1.12 4 16 1.12 0.74 4
 Procalcitonin (≤0.5(ng/ml) 0.037 < 0.02 0.032 0.17 0.035 < 0.02 0.02
GLU(3.9–6.1 mmol/L) 4.9 5.5 5.2 7.74 4.9 4.8 4.1
 Alanine aminotransferase (8-40 U/L) 25 4 7 8 18 13 10
 Aspartate aminotransferase (5-40 U/L) 14 9 18 12 24 14 9
 Urea nitrogen (2.9–8.2 m mol/L) 4 2.2 13 8.94 5.2 3 1.9
 Creatinine (40-106umol/L) 87.3 81.2 3.7 58.1 85.8 55 54.1
 Glutamyl transpeptidase (8-58 U/L) 34 12 50.6 18 22 17 16
 Lactate dehydrogenase (115-220 U/L) 155 117 177 180 171 114 162
 Total bilirubin (5.1-20umol /L) 12.6 3.6 6.2 6 4 3.7 6.5
 Direct bilirubin (0–6.8 u mol/L) 1.7 1.3 1.6 1.2 2 1.2 1.1
 Indirect bilirubin (2–17 umol/L) 10.9 2.3 4.6 4.8 2 2.5 5.4
 Myoglobin (<21 ng/ml) 28.99 < 21 < 21 < 21 23.49 < 21 < 21
 Creatine kinase (25–196 U/L) 119 32 67 39 28 23 30
 Creatinase isoenzyme (0- 26 U/L) 6 3 4 26 7 2 8
 Troponin (0–0.1 ng/ml) 0.037 < 0.003 0.003 < 0.001 0.006 < 0.003 < 0.003
 APTT (26-44 s) 36 31.4 36 35.7 30.7 31.5 33.3
 D-dimer (0-1 mg/ml) 0.89 0.47 0.3 2.73 0.43 0.44 0.45
 BNP<300 pg/ml) 196